Shuichiro Kakimoto

发表

Gene mutation in hereditary progressive dystonia with marked diurnal fluctuation (HPD), strictly defined dopa-responsive dystonia

N. Nishiyama, M. Segawa, Y. Nomura, 2000, Brain and Development.

Amelioration of Neuropathic Pain by Novel Transient Receptor Potential Vanilloid 1 Antagonist AS1928370 in Rats without Hyperthermic Effect

T. Aoki, N. Matsuoka, A. Kohara, 2011, Journal of Pharmacology and Experimental Therapeutics.

AS1069562, the (+)-Isomer of Indeloxazine, Exerts Analgesic Effects in a Rat Model of Neuropathic Pain with Unique Characteristics in Spinal Monoamine Turnover

T. Aoki, N. Matsuoka, T. Sekizawa, 2014, The Journal of Pharmacology and Experimental Therapeutics.

A novel GABAB receptor positive allosteric modulator, ASP8062, exerts analgesic effects in a rat model of fibromyalgia.

M. Matsumoto, S. Akuzawa, T. Mihara, 2019, European journal of pharmacology.

In vitro and in vivo pharmacological characterization of ASP8477: A novel highly selective fatty acid amide hydrolase inhibitor

T. Ozawa, N. Tsuji, T. Watabiki, 2017, European journal of pharmacology.

Analgesic effects of ASP3662, a novel 11β‐hydroxysteroid dehydrogenase 1 inhibitor, in rat models of neuropathic and dysfunctional pain

T. Sekizawa, H. Uchino, T. Kiso, 2018, British journal of pharmacology.

Microsoft Word - 82537608-file00.docx

T. Aoki, T. Sekizawa, Nozomu Hamakawa, 2013 .

Spontaneous and evoked pain-associated behaviors in a rat model of neuropathic pain respond differently to drugs with different mechanisms of action

T. Sekizawa, T. Watabiki, Y. Nagakura, 2016, Pharmacology Biochemistry and Behavior.

Corrigendum to “Discovery of novel tetrahydroisoquinoline derivatives as orally active N-type calcium channel blockers with high selectivity for hERG potassium channels” [Bioorg. Med. Chem. 22 (2014) 6899–6907]

M. Inoue, Hiroyoshi Yamada, Toshihiro Watanabe, 2015 .

Minodronic acid, a third-generation bisphosphonate, antagonizes purinergic P2X(2/3) receptor function and exerts an analgesic effect in pain models.

M. Sasamata, M. Okada, S. Tamura, 2008, European journal of pharmacology.

Assessment of canine sensory function by using sine-wave electrical stimuli paradigm

T. Yaksh, T. Watabiki, Y. Nagakura, 2010, Physiology and Behavior.

A KCa3.1 Channel Opener, ASP0819, Modulates Nociceptive Signal Processing from Peripheral Nerves in Fibromyalgia-Like Pain in Rats

T. Kiso, S. Kakimoto, N. Takeshita, 2021, Journal of pain research.

Amelioration of Neuropathic Pain by Novel Transient Receptor Potential Vanilloid 1 Antagonist AS1928370 in Rats without Hyperthermic Effect

T. Aoki, N. Matsuoka, A. Kohara, 2011, Journal of Pharmacology and Experimental Therapeutics.

Spontaneous and evoked pain-associated behaviors in a rat model of neuropathic pain respond differently to drugs with different mechanisms of action

T. Sekizawa, T. Watabiki, Y. Nagakura, 2016, Pharmacology Biochemistry and Behavior.

Discovery of a 1-isopropyltetrahydroisoquinoline derivative as an orally active N-type calcium channel blocker for neuropathic pain.

M. Inoue, Toshihiro Watanabe, Akiko Koakutsu, 2015, Bioorganic & medicinal chemistry.

Discovery of novel tetrahydroisoquinoline derivatives as orally active N-type calcium channel blockers with high selectivity for hERG potassium channels.

M. Inoue, Hiroyoshi Yamada, Toshihiro Watanabe, 2014, Bioorganic & medicinal chemistry.